Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2021-05-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于公司完成经营范围变更备案的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of a change in the company's business scope and the corresponding amendment to the company bylaws. It references a shareholders' meeting where the change was approved and mentions the official filing with the local market supervision bureau. The document is short (650 characters) and serves as a formal notice of a corporate administrative update rather than a financial report or detailed management discussion. It does not contain financial data, audit information, or voting results. It is not a report publication announcement since it does not mention the release of a report but rather the completion of a regulatory filing related to business scope change. The closest fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-05-25 Chinese
公司章程（2021年5月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 厦门艾德生物医药科技股份有限公司, dated May 2021. It contains detailed provisions on company organization, shareholder rights, board structure, share issuance, shareholder meetings, and other governance matters. It is a comprehensive internal governance document rather than a financial report, announcement, or meeting material. The content aligns with governance information about the company's internal rules and board structure. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the bylaws, not a brief announcement or summary.
2021-05-25 Chinese
关于2019年限制性股票激励计划首次授予部分第二个解除限售期解除限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under a 2019 restricted stock incentive plan. It includes specifics about the number of shares, conditions met for lifting restrictions, board and supervisory committee approvals, legal opinions, and changes in share capital structure. The content focuses on the company's stock incentive plan and the release of restricted shares for trading, which is a capital structure change related to share issuance and restrictions lifting. It is not a full financial report, audit report, or earnings release, nor is it a simple announcement of a report publication. The document is a formal announcement about share capital changes due to stock incentive plan unlocking, fitting best under the category of Share Issue/Capital Change (SHA).
2021-05-14 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the receipt of an invention patent certificate by the company. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, no management or board changes, no voting results, and no other report types. It is a regulatory announcement about intellectual property. Given the short length (497 characters) and the nature of the content, it does not fit into any financial report category but is a general regulatory announcement. Therefore, the best fitting category is Regulatory Filings (RNS).
2021-05-11 Chinese
关于2019年限制性股票激励计划预留授予部分第一个解除限售期解除限售股份上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under the company's 2019 restricted stock incentive plan. It includes specifics about the number of shares, conditions for unlocking, board and supervisory approvals, performance criteria, and changes in share capital structure. The document is not a full annual or interim financial report, nor is it a simple announcement of a report publication. It is a regulatory announcement about share unlocking related to stock incentives, which fits best under the category of Regulatory Filings (RNS) as it does not match other more specific categories like Director's Dealing or Share Issue/Capital Change, since it focuses on the lifting of restrictions on previously granted shares rather than new share issuance or insider trading. The document length and detail also support it being a substantive regulatory filing rather than a brief announcement or a report publication notice.
2021-05-10 Chinese
2020年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2020年度股东大会决议公告" which translates to "2020 Annual General Meeting Resolution Announcement." It details the resolutions passed at the 2020 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the board report, financial report, profit distribution plan, and other corporate matters. The document includes detailed voting statistics and legal opinions confirming the validity of the meeting and its resolutions. There is no full financial report or detailed financial statements included, only the announcement of the voting results and resolutions passed at the AGM. The document length is 4443 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of "Declaration of Voting Results & Voting Rights Announcements (DVA)" as it officially announces the results of shareholder votes at the AGM.
2021-05-07 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.